Penn Medicine
Help | Search | Site Map | Contact   

Chenbo Zeng, PhD

faculty photo
Research Assistant Professor of Radiology
Department: Radiology

Contact information
Department of Radiology
University of Pennsylvania
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-746-2511
Education:
B.A. (Biochemistry)
Jilin University, Changchun, P.R. China, 1985.
M.S. (Biochemistry)
Jilin University, Changchun, P.R. China, 1988.
Ph.D (Biochemistry)
Iowa State University, Ames, Iowa, 1996.
Post-Graduate Training
research associate, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, MO, 1997-1999.
Research Associate, Renal Division, Washington University School of Medicine, St. Louis, MO, 1999-2001.
Research Associate , Department of Neurology, Washington University School of Medicine, St. Louis, MO, 2002-2004.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Studying the biological functions of the sigma-2 receptor in breast cancer and in the central nervous system

Selected Publications

Sellmyer MA, Lee I, Hou C, Lieberman BP, Zeng C, Mankoff DA, Mach RH.: Quantitative PET Reporter Gene Imaging with [11C]Trimethoprim. Mol Ther. 25(1): 120-126, 2017.

Chenbo Zeng and Robert H. Mach: The Evolution of the Sigma-2 Receptor from Obscure Binding Site to Bona Fide Therapeutic Target. Adv Exp Med Biol. Sigma Receptors: Their Role in Disease and as Therapeutic Targets. Sylvia B. Smith and Tsung-Ping Su (eds.). Springer, 964: 49-61, 2017.

Chenbo Zeng, Elizabeth S. McDonald, Robert H Mach: Molecular probes for imaging the sigma-2 receptor: in vitro and in vivo imaging studies Handb Exp Pharmacol. Sigma Proteins - Molecular pharmacology in physiology and pathophysiology. Felix J Kim Gavril Pasternak (eds.). Springer, 2017.

Elizabeth S. McDonald, Julia Mankoff, Mehran Makvandi, Wenhua Chu, Yunxiang Chu, Robert H Mach, Chenbo Zeng: Sigma-2 ligands and PARP inhibitors synergistically trigger cell death in breast cancer cells Biochemical and Biophysical Research Communications 486: 788-795 2017 Notes: Epub ahead of print.

Anderson RC, Makvandi M, Xu K, Lieberman BP, Zeng C, Pryma DA, Mach RH.: Iodinated benzimidazole PARP radiotracer for evaluating PARP1/2 expression in vitro and in vivo. Nucl Med Biol. 43(12): 752-758, 2016.

Makvandi M, Xu K, Lieberman BP, Anderson RC, Effron SS, Winters HD, Zeng C, McDonald ES, Pryma DA, Greenberg RA, Mach RH.: A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy. Cancer Res. 76(15): 4516-24, 2016.

Zeng C, Garg N, Mach RH.: The PGRMC1 Protein Level Correlates with the Binding Activity of a Sigma-2 Fluorescent Probe (SW120) in Rat Brain Cells. Mol Imaging Biol. 18: 172-9, 2016.

Edmonds CE, Makvandi M, Lieberman BP, Xu K, Zeng C, Li S, Hou C, Lee H, Greenberg RA, Mankoff DA, Mach RH.: [(18)F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancer. Am J Nucl Med Mol Imaging. 6: 94-101, 2016.

Makvandi M, Tilahun ED, Lieberman BP, Anderson RC, Zeng C, Xu K, Hou C, McDonald ES, Pryma DA, Mach RH.: The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancer. Biochem Biophys Res Commun 467: 1070-5, 2015

Elizabeth S. McDonald, Chenbo Zeng, David A Mankoff, Andrew Kossenkov, Robert H Mach: PGRMC1 expression is significantly up-regulated in triple negative breast cancer in vivo with associated activation of cyclin D1 target genes: Analysis of 1019 invasive breast cancers in the TCGA database. 2015 Annual Meeting American Association for Cancer Research 2015.

back to top
Last updated: 04/11/2017
The Trustees of the University of Pennsylvania
 
© The Trustees of the University of Pennsylvania. Site best viewed with Mozilla, NN, IE, or Safari.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration